| Literature DB >> 33519230 |
Peize Zhang1, Juan Xiong2, Jianfeng Zeng1, Senlin Zhan1, Tao Chen1, Yuxiang Wang1, Guofang Deng1.
Abstract
OBJECTIVE: The aim of this study was to assess active tuberculosis-related deaths in Shenzhen city of China to identify major causes of mortality in different age groups. PATIENTS AND METHODS: Medical records of mortality cases of patients with active TB diagnosed during 2013-2018 were reviewed. All TB deaths were classified into two broad age groups (the young group: 18-65 years old and the elderly group: >65 years old). Causes of death were analyzed based on medical records.Entities:
Keywords: TB-related death; active tuberculosis; tuberculosis comorbidity; tuberculosis complication; young death
Year: 2021 PMID: 33519230 PMCID: PMC7837593 DOI: 10.2147/IJGM.S291146
Source DB: PubMed Journal: Int J Gen Med ISSN: 1178-7074
Figure 1Age distribution of TB-related deaths in this study.
Basic Characteristics of Patients in This Study
| Characteristics | Age Group | ||
|---|---|---|---|
| Young Group | Elderly Group | ||
| n=192 | n=87 | ||
| 0.704 | |||
| Male | 156 (81.3%) | 69 (79.3%) | |
| Female | 36 (18.7%) | 18 (20.7%) | |
| 15 (7.8%) | 0 | — | |
| 2 (1.0%) | 0 | — | |
| 8 | 8 | 1.00 | |
| Miliary TB and tuberculous meningitis | 45 (23.4%) | 7 (8.0%) | 0.002 |
| PTB | 125 (65.1%) | 67 (77.0%) | 0.047 |
| Extra-PTB | 9 (4.7%) | 5 (5.7%) | 0.707 |
| Multi-system tuberculosis | 14 (7.3%) | 8 (9.2%) | 0.585 |
| 0.278 | |||
| Newly treated TB | 172 (89.6%) | 74 (85.1%) | |
| Retreated TB | 20 (10.4%) | 13 (14.9%) | |
| 11 (5.7%) | 4 (4.6%) | 0.698 | |
Abbreviations: TB, tuberculosis; PTB, pulmonary tuberculosis; MDR/XDR-TB, multidrug-resistant/extensively drug-resistant tuberculosis.
Comorbidities Among Patients in This Study
| Comorbidity | Age Group | ||
|---|---|---|---|
| Young Group | Elderly Group | ||
| n=192 | n=87 | ||
| HIV co-infection | 40 (20.8%) | 2 (2.3%) | <0.001 |
| Diabetes | 24 (12.5%) | 29 (33.3%) | <0.001 |
| Cancer | 9 (4.7%) | 10 (11.5%) | 0.037 |
| End-stage renal disease | 3 (1.6%) | 5 (5.7%) | 0.052 |
| Liver cirrhosis/failure | 10 (5.2%) | 7 (8.0%) | 0.359 |
| Cardiovascular disease | 26 (13.5%) | 46 (52.9%) | <0.001 |
| COPD | 4 (2.1%) | 14 (16.1%) | <0.001 |
| Malnutrition | 83 (43.2%) | 31 (35.6%) | 0.232 |
| Others* | 4 (2.1%) | 6 (6.9%) | 0.045 |
Note: *Included rheumatic diseases and other immune-compromised diseases.
Abbreviation: COPD, chronic obstructive pulmonary disease.
Complications Among Patients in This Study
| Complication | Age Group | ||
|---|---|---|---|
| Young Group | Elderly Group | ||
| n=192 | n=87 | ||
| Bacterial pneumonia | 56 (27.1%) | 16 (18.4%) | 0.057 |
| Septic shock | 35 (18.2%) | 11 (12.6%) | 0.974 |
| Respiratory failure | 23 (12.0%) | 10 (11.5%) | 0.908 |
| Hemoptysis | 13 (6.8%) | 9 (10.3%) | 0.305 |